tiprankstipranks
Advertisement
Advertisement

AU:IMM Stock Latest News

Immutep Ends Key Lung Cancer Trial but Stresses Strength of Pipeline
Company AnnouncementsImmutep Ends Key Lung Cancer Trial but Stresses Strength of Pipeline
3d ago
Immutep sees progress from Phase I study of LAG-3 agonist for autoimmune disease
PremiumThe Fly
Immutep sees progress from Phase I study of LAG-3 agonist for autoimmune disease
23d ago
IMMP
Insignia Financial Ceases to Be Substantial Holder in Immutep
PremiumCompany Announcements
Insignia Financial Ceases to Be Substantial Holder in Immutep
23d ago
Immutep Reports Positive Phase I Progress for First-in-Class Autoimmune Drug IMP761
PremiumCompany Announcements
Immutep Reports Positive Phase I Progress for First-in-Class Autoimmune Drug IMP761
24d ago
UBS Group Ceases to Be Substantial Shareholder in Immutep
PremiumCompany Announcements
UBS Group Ceases to Be Substantial Shareholder in Immutep
24d ago
Immutep downgraded to Hold from Buy at Maxim
PremiumThe FlyImmutep downgraded to Hold from Buy at Maxim
29d ago
IMMP
Adobe downgraded, Nio upgraded: Wall Street’s top analyst calls
Premium
The Fly
Adobe downgraded, Nio upgraded: Wall Street’s top analyst calls
29d ago
AA
PD
Immutep says IDMC recommends discontinuation for TACTI-004 Phase III study
Premium
The Fly
Immutep says IDMC recommends discontinuation for TACTI-004 Phase III study
29d ago
IMMP
Immutep downgraded to Neutral from Outperform at Baird
PremiumThe Fly
Immutep downgraded to Neutral from Outperform at Baird
29d ago
IMMP
Immutep downgraded to Market Perform from Outperform at Citizens
PremiumThe Fly
Immutep downgraded to Market Perform from Outperform at Citizens
29d ago
IMMP
Immutep Trading Resumes on ASX After Key Phase III Trial Update
PremiumCompany Announcements
Immutep Trading Resumes on ASX After Key Phase III Trial Update
30d ago
Immutep Halts Pivotal Lung Cancer Trial After Futility Review
PremiumCompany Announcements
Immutep Halts Pivotal Lung Cancer Trial After Futility Review
30d ago
Immutep Shares Suspended Pending Key Phase III Trial Futility Update
PremiumCompany AnnouncementsImmutep Shares Suspended Pending Key Phase III Trial Futility Update
1M ago
Immutep Halts Trading Ahead of Key Phase III Trial Futility Analysis
Premium
Company Announcements
Immutep Halts Trading Ahead of Key Phase III Trial Futility Analysis
1M ago
Immutep Doubles Half-Year Loss as R&D Spend Surges Despite New Collaboration Revenue
Premium
Company Announcements
Immutep Doubles Half-Year Loss as R&D Spend Surges Despite New Collaboration Revenue
2M ago
Immutep initiated with an Outperform at Citizens
PremiumThe Fly
Immutep initiated with an Outperform at Citizens
2M ago
IMMP
Immutep achieves 50% enrollment in global TACTI-004 Phase III trial
PremiumThe Fly
Immutep achieves 50% enrollment in global TACTI-004 Phase III trial
2M ago
IMMP
Immutep Hits 50% Enrolment Milestone in Global Phase III Lung Cancer Trial
PremiumCompany Announcements
Immutep Hits 50% Enrolment Milestone in Global Phase III Lung Cancer Trial
2M ago
Immutep reports Q2 cash receipts from customers A$4,000
PremiumThe Fly
Immutep reports Q2 cash receipts from customers A$4,000
2M ago
IMMP
Immutep Secures Dr. Reddy’s Partnership and Strengthens Clinical, Financial Position
PremiumCompany AnnouncementsImmutep Secures Dr. Reddy’s Partnership and Strengthens Clinical, Financial Position
2M ago
Immutep announces update on IMP761 from Phase I study
Premium
The Fly
Immutep announces update on IMP761 from Phase I study
4M ago
IMMP
Immutep Reports Promising Phase I Data for First-in-Class Autoimmune Antibody IMP761
Premium
Company Announcements
Immutep Reports Promising Phase I Data for First-in-Class Autoimmune Antibody IMP761
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >